SCHEMBL88252

SCHEMBL88252

Cc1ccc(C(=O)OC(C(=O)O)(C(=O)c2ccc(C)cc2)C(O)C(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 5/20 0.39
LMNA P02545 1/20 0.39
SRD5A2 P31213 1/20 0.39
CA2 P00918 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 2/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
MAPT P10636 3/20 0.36
CES2 O00748 2/20 0.35
CES1 P23141 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
AKR1C3 P42330 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72683 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL27955132 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL72172 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL5461407 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL6532888 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL2986285 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL7348978 0.99 TDP1 (0.41) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL7355024 0.99 TDP1 (0.41) TDP1ALDH1A1LMNASRD5A2CA2
Water SCHEMBL3859938 0.99 TDP1 (0.41) TDP1ALDH1A1LMNASRD5A2CA2
Water SCHEMBL1322825 0.99 TDP1 (0.41) TDP1ALDH1A1LMNASRD5A2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3826 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441745-B2 Processes and compounds RADIUS PHARMACEUTICALS, INC. (US) 2025-10-14 US claimed
CN-119954778-A Synthesis method of lenacipam sodium and series of intermediate compounds thereof 杭州科巢生物科技有限公司 2025-05-09 CN claimed
CN-119569588-A Preparation method and intermediate of ilast hydrochloride 杭州诺澳生物医药科技有限公司 2025-03-07 CN claimed
CN-119409612-A Resolution refining method of clemastine fumarate 南京斯泰尔医药科技有限公司 2025-02-11 CN claimed
CN-113348163-B Methods and compounds 雷迪厄斯制药公司 2024-10-08 CN claimed
CN-117964625-A Preparation method of high-optical-purity ponatinib intermediate 安徽万邦医药科技股份有限公司 2024-05-03 CN claimed
CN-117843552-A Resolution method of cis-4-amino-3-methoxypiperidine-1-formate optical isomer 中国医学科学院药物研究所 2024-04-09 CN claimed
CN-117843454-A Menthol slow-release eutectic compound and preparation method and application thereof 湖北中烟工业有限责任公司 2024-04-09 CN claimed
US-11905292-B2 Process and intermediates for preparing a JAK inhibitor INCYTE CORPORATION (US) 2024-02-20 US claimed
CN-116761792-A Methods and intermediates for preparing JAK inhibitors 因赛特公司 2023-09-15 CN claimed
EP-0539460-B1 SALTS DERIVED FROM DIALKYLAMINOALKYLSULPHONYL-26 PRISTINAMYCIN II B RHONE POULENC RORER SA (FR) 1994-10-05 EP claimed
EP-0575482-A1 ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE EMORY UNIVERSITY (US) 1993-12-29 EP claimed
EP-0539460-A1 SALTS DERIVED FROM DIALKYLAMINOALKYLSULPHONYL-26 PRISTINAMYCIN II B. RHONE POULENC RORER SA (FR) 1993-05-05 EP claimed
WO-1992014743-A2 ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE EMORY UNIVERSITY (US) 1992-09-03 WO claimed
WO-1992001694-A1 NEW SALTS DERIVED FROM DIALKYLAMINOALKYLSULPHONYL-26 PRISTINAMYCIN II¿B? RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO claimed
EP-0365213-A2 Method of resolving cis 3-amino-4-[2-(2-furyl)vinyl]-1-methoxy-carbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof ELI LILLY AND COMPANY (US) 1990-04-25 EP claimed
EP-0251904-B1 PROCESS FOR THE PREPARATION OF ACIDIC LEVOMEPROMAZINE MALEATE RHONE-POULENC SANTE (FR) 1990-01-10 EP claimed
US-4798895-A Process for preparing levomepromazine hydrogen maleate RHONE-POULENC SANTE (FR) 1989-01-17 US claimed
US-4471121-A Method of resolving trans-d alpha-1-n-propyl-6-oxodecahydroquinoline and di-p-toluoyltartaric acid salts thereof ELI LILLY AND COMPANY (US) 1984-09-11 US claimed
EP-0112604-A1 Novel resolved keto compounds and process ELI LILLY AND COMPANY (US) 1984-07-04 EP claimed